Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LUMINA: Febuxostat for Cardiovascular Outcomes in Peritoneal Dialysis Patients with Hyperuricemia
NCT03200210Phase 4Unknown
- Sponsor
- Sun Yat-sen University
- Start
- Jul 2017
- Primary completion
- Dec 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of febuxostat in hyperuricemia, sponsored by Sun Yat-sen University. Status: unknown.
02
Drugs
febuxostat
03
Conditions
hyperuricemia
Beyond the preview
Go deeper on NCT03200210.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03200210.